1. "2017"
  2. "Michael Postow"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (12)
Groups
  1. Department of Medicine (39)
  2. Melanoma Disease Management Team (39)
  3. Melanoma and Immunotherapeutics Service (39)
  4. Solid Tumor Oncology Division (39)
  5. GSK Faculty (22)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)

More Groups

People
  1. Michael Postow (39)
  2. Jedd Wolchok (20)
  3. Alexander Shoushtari (7)
  4. Margaret Callahan (7)
  5. Paul Chapman (7)
  6. Katherine Panageas (6)

More People

Years
  1. 2017 (39)
Publications
  1. Journal of Clinical Oncology (7)
  2. Journal for ImmunoTherapy of Cancer (6)
  3. Journal of Translational Medicine (3)
  4. Annals of Oncology (2)
  5. European Journal of Cancer (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. Biomed Central Ltd (9)
  2. American Society of Clinical Oncology (8)
  3. Elsevier Inc. (6)
  4. Elsevier Science, Inc. (3)
  5. Lippincott Williams & Wilkins (3)
  6. Oxford University Press (3)

More Publishers

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204
    Meeting Abstract

    Tawbi, H. A. H.; Forsyth, P. A. J.; Algazi, A. P.; Hamid, O.; Hodi, F. S.; Moschos, S. J.; Khushalani, N. I.; Gonzalez, R.; Lao, C. D.; Postow, M. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1b/2 trial of ribociclib plus binimetinib in metastatic NRAS-mutant melanoma: Safety, efficacy, and recommended phase 2 dose (RP2D)
    Meeting Abstract

    Schuler, M. H.; Ascierto, P. A.; De Vos, F. Y. F. L.; Postow, M. A.; Van Herpen, C. M. L.; Carlin, M. S.; Sosman, J. A.; Berking, C.; Long, G. V.; Weise, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and immunologic variables associated with outcomes following combination ipilimumab and nivolumab immunotherapy in melanoma
    Meeting Abstract

    Rosner, S.; Kwong, E.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors
    Meeting Abstract

    Friedman, C. F.; Wolchok, J. D.; Postow, M. A.; Shoushtari, A. N.; Callahan, M. K.; Momtaz, P.; Chapman, P. B.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Monotherapy dose escalation clinical and translational data from first-in-human study in advanced solid tumors of IPI-549, an oral, selective, PI3K-gamma inhibitor targeting tumor macrophages
    Meeting Abstract

    Hong, D.; Tolcher, A.; Sullivan, R.; Shapiro, G.; Chmielowski, B.; Ribas, A.; Brail, L.; Pearlberg, J.; Mahabhashyam, S.; Lee, L.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phase 1/1b, first-in-human study of the PI3K-gamma inhibitor IPI-549 as monotherapy and combined with nivolumab in patients with advanced solid tumors
    Meeting Abstract

    Ribas, A.; Hong, D.; Tolcher, A.; Sullivan, R.; Shapiro, G.; Chmielowski, B.; Brail, L.; Lee, L.; Mahabhashyam, S.; Ullmann, C. D.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Pooled 3-year overall survival data from phase II and phase III trials of nivolumab (NIVO) combined with ipilimumab (IPI) in advanced melanoma
    Meeting Abstract

    Postow, M.; Larkin, J.; Wolchok, J.; Chiarion-Sileni, V.; Hodi, F. S.; Rutkowsk, P.; Grob, J. J.; Grossmann, K.; Schadendorf, D.; Chesney, J.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Treatment of advanced melanoma - A changing landscape
    Journal Article

    Hepner, A.; Salgues, A.; dos Anjos, C. A.; Sahade, M.; Camargo, V. P.; Garicochea, B.; Shoushtari, A. N.; Postow, M. A.; Fernandes, G. S.; Munhoz, R. R.
    Revista Da Associacao Medica Brasileira (2017)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of MEK inhibitor - Associated retinopathy: Differences from central serous chorioretinopathy
    Journal Article

    Francis, J. H.; Habib, L. A.; Abramson, D. H.; Yannuzzi, L. A.; Heinemann, M.; Gounder, M. M.; Grisham, R. N.; Postow, M. A.; Shoushtari, A. N.; Chi, P.; more...
    Ophthalmology (2017)

    Fulltext@MSK | Save